Search
  • JPG

Returning to Work Safely: A Use Case for Antibody Testing

Updated: Jun 3


A use case for antibody testing as a standalone screening program:


· All employees returning to work are screened using a symptom questionnaire

· Those employees who are asymptomatic are eligible to be tested

· People who are symptomatic can be tested for antibodies 14 days after symptoms

· Antibody test results (conducted on employees who are symptom-free)

· If the test is positive for Ig G only, the person can return to duty

· If the test reveals a mixed antibody response, the person remains out for 14 more days

· A repeat antibody test is done to confirm only Ig G is present

· If the test is negative, the person can return to duty

· If respiratory symptoms arise, the person should be removed from duty

· Repeat antibody testing after 7 days



Comprehensive COVID-19 Testing Program:


Leveraging the strengths of antibody and viral antigen testing provides employers the most robust testing solution for COVID-19. Antibody tests look for exposure, and antigen test looks for contagion. Looking at staging these two tests affords a company a program that provides objective proof of immunity status and contagion.


The use case for a blended comprehensive program looks like this:


· All employees returning to work are screened using a symptom questionnaire

· Those employees who are asymptomatic are eligible to be tested

· People who are symptomatic can be tested for 14 days after resolution of symptoms

· The initial test is an antibody test (conducted on employees who are symptom-free)

· If the test is positive, an immediate viral antigen test is conducted

· If the test is negative, the person can return to workplace duties

· For those who are antibody positive

· If the viral antigen test is negative, this person can return to duty

· This person is likely immune to COVID-19

· If the viral antigen test is positive, the person should be removed from duty

· Repeat antibody testing after 7 days

#BuyAntibodyTest


Contact Jim Grimmer jpgrimmer@att.net for more information

23 views

Recent Posts

See All

Disclaimer:

This test has been widely used in the Asian and European markets

 

For US market, we have received EUA (Emergency Use Authorization), and the products also can be sold with this special warning statement on package "The test has been reviewed by the FDA and results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.